| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Announcements
|
|
|
2001
|
38 |
3 |
p. 321-322
2 p.
|
artikel
|
| 2 |
A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease
|
|
|
2001
|
38 |
3 |
p. 219-220
2 p.
|
artikel
|
| 3 |
Author index
|
|
|
2001
|
38 |
3 |
p. 323-324
2 p.
|
artikel
|
| 4 |
Cardiovascular protection by postmenopausal hormone replacement therapy — the point of lower oestrogen dosages
|
van der Mooren, M.J.
|
|
2001
|
38 |
3 |
p. 227-229
3 p.
|
artikel
|
| 5 |
Controversial issues in climacteric medicine (I) Cardiovascular disease and hormone replacement therapy. International Menopause Society Expert Workshop, 13–16 October 2000, Royal Society of Medicine, London, UK
|
Genazzani, A.R
|
|
2001
|
38 |
3 |
p. 263-271
9 p.
|
artikel
|
| 6 |
Do women using hormone replacement treatment have less pre-existing cardiovascular risk
|
Blümel, J.E
|
|
2001
|
38 |
3 |
p. 315-319
5 p.
|
artikel
|
| 7 |
Effect on biochemical vasoactive markers during postmenopausal hormone replacement therapy: estradiol versus estradiol/dienogest
|
Mueck, Alfred O
|
|
2001
|
38 |
3 |
p. 305-313
9 p.
|
artikel
|
| 8 |
Effects of bezafibrate and simvastatin on plasma lipoproteins in hypercholesterolemia resistant to hormone replacement therapy
|
Ohmichi, Masahide
|
|
2001
|
38 |
3 |
p. 279-286
8 p.
|
artikel
|
| 9 |
Hormone replacement therapy and cardiovascular risk: consistency of results and unreliable data
|
Rosano, Giuseppe M.C
|
|
2001
|
38 |
3 |
p. 225-226
2 p.
|
artikel
|
| 10 |
Hormone replacement therapy and stroke: risk, protection or no effect?
|
Paganini-Hill, Annlia
|
|
2001
|
38 |
3 |
p. 243-261
19 p.
|
artikel
|
| 11 |
HRT and heart disease: Dr Jekyll or Mrs Hyde?
|
van der Schouw, Yvonne T
|
|
2001
|
38 |
3 |
p. 213-217
5 p.
|
artikel
|
| 12 |
Instructions to authors
|
|
|
2001
|
38 |
3 |
p. 333-334
2 p.
|
artikel
|
| 13 |
Opinion survey towards hormone replacement therapy in the prevention of coronary heart disease
|
Rozenberg, Serge
|
|
2001
|
38 |
3 |
p. 273-277
5 p.
|
artikel
|
| 14 |
Phenotype of apolipoprotein E influences the lipid metabolic response of postmenopausal women to hormone replacement therapy
|
Tsuda, Mikio
|
|
2001
|
38 |
3 |
p. 297-304
8 p.
|
artikel
|
| 15 |
Postmenopausal hormone therapy and primary prevention of cardiovascular disease — Nurses’ health study 20-year follow-up
|
Speroff, L
|
|
2001
|
38 |
3 |
p. 221-224
4 p.
|
artikel
|
| 16 |
Response to comments on ‘A Prospective, Observational Study of Postmenopausal Hormone Therapy and Primary Prevention of Cardiovascular Disease’
|
Grodstein, Francine
|
|
2001
|
38 |
3 |
p. 239-241
3 p.
|
artikel
|
| 17 |
Subject index
|
|
|
2001
|
38 |
3 |
p. 325-327
3 p.
|
artikel
|
| 18 |
The effect of oral hormone replacement therapy on lipoprotein profile, resistance of LDL to oxidation and LDL particle size
|
Hermenegildo, Carlos
|
|
2001
|
38 |
3 |
p. 287-295
9 p.
|
artikel
|
| 19 |
The Nurses’ Health Study: unresolved issues after 20-years follow-up
|
Pines, A
|
|
2001
|
38 |
3 |
p. 231-233
3 p.
|
artikel
|
| 20 |
The Queen… is naked!
|
Neves-e-Castro, M
|
|
2001
|
38 |
3 |
p. 235-237
3 p.
|
artikel
|
| 21 |
Volume contents
|
|
|
2001
|
38 |
3 |
p. 329-331
3 p.
|
artikel
|
Tijdschrift beschrijving